SeaSpine Investor Update

$ $56.3M Total Revenue (an increase of 19% YoY) $24.5M US Orthobiologics Revenue (an increase of 16% YoY) ($) $49.5M US Revenue (an increase of 16% YoY) Livi 66.0% 67.9% ADJUSTED Gross Margin GAAP $25.0M US Spinal Implants & Enabling Technologies Revenue (an increase of 17% YoY) APRI $ $66.1M Liquidity Cash at 6/30/22 Ⓒ2022 SeaSpine Orthopedics Corporation. All rights reserved | 18 Q2 Highlights 2022 Financial Results SeaSpine

View entire presentation